1. Home
  2. |Insights
  3. |PODCAST: Aviation and the FAA: Unmanned Aircraft Systems — C&M’s First 100 Days Series

PODCAST: Aviation and the FAA: Unmanned Aircraft Systems — C&M’s First 100 Days Series

Client Alert | 1 min read | 12.14.16

As part of Crowell & Moring’s “First 100 Days” podcast series, Marc Warren, chair of the firm’s Aviation Group, and Steve Seiden, counsel in the group, sit down to discuss how the Trump Administration might affect the regulatory climate for commercial drones. Marc previously served as the deputy chief counsel of the Federal Aviation Administration, and Steve also served the FAA in various capacities, including a one-year assignment as special counsel to the agency’s chief counsel.

Discussed in this 18 minute podcast:

  • Why Unmanned Aircraft Systems (UAS) are the next big thing, their potential, and industry and business applications.
  • Current state of regulatory play – pilot requirements, when and where drones can be flown, and the waiver process.
  • Opportunities and challenges for the Trump Administration.
  • Near-term issues (a forthcoming notice of proposed rulemaking on microdrones).
  • What’s next? (large drones, operations over people, and fully autonomous drones).
  • Other issues worth tracking (Federal preemption, potential conflicts with state laws, and privacy issues).

Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes

Insights

Client Alert | 3 min read | 01.21.26

Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement

On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion....